13-101104660-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_052867.4(NALCN):c.2637-10T>G variant causes a splice polypyrimidine tract, intron change. The variant allele was found at a frequency of 0.025 in 1,613,486 control chromosomes in the GnomAD database, including 680 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.027 ( 73 hom., cov: 33)
Exomes 𝑓: 0.025 ( 607 hom. )
Consequence
NALCN
NM_052867.4 splice_polypyrimidine_tract, intron
NM_052867.4 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.8343
2
Clinical Significance
Conservation
PhyloP100: 4.23
Genes affected
NALCN (HGNC:19082): (sodium leak channel, non-selective) This gene encodes a voltage-independent, nonselective cation channel which belongs to a family of voltage-gated sodium and calcium channels that regulates the resting membrane potential and excitability of neurons. This family is expressed throughout the nervous system and conducts a persistent sodium leak current that contributes to tonic neuronal excitability. The encoded protein forms a channelosome complex that includes G-protein-coupled receptors, UNC-79, UNC-80, NCA localization factor-1, and src family tyrosine kinases. Naturally occurring mutations in this gene are associated with infantile neuroaxonal dystrophy, infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) syndrome, and congenital contractures of the limbs and face with hypotonia and developmental delay (CLIFAHDD) syndrome. A knockout of the orthologous gene in mice results in paralysis with a severely disrupted respiratory rhythm, and lethality within 24 hours after birth. [provided by RefSeq, Apr 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 13-101104660-A-C is Benign according to our data. Variant chr13-101104660-A-C is described in ClinVar as [Benign]. Clinvar id is 262258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-101104660-A-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0634 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NALCN | NM_052867.4 | c.2637-10T>G | splice_polypyrimidine_tract_variant, intron_variant | ENST00000251127.11 | NP_443099.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NALCN | ENST00000251127.11 | c.2637-10T>G | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_052867.4 | ENSP00000251127 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0265 AC: 4036AN: 152140Hom.: 70 Cov.: 33
GnomAD3 genomes
AF:
AC:
4036
AN:
152140
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0268 AC: 6703AN: 250344Hom.: 124 AF XY: 0.0278 AC XY: 3765AN XY: 135258
GnomAD3 exomes
AF:
AC:
6703
AN:
250344
Hom.:
AF XY:
AC XY:
3765
AN XY:
135258
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0248 AC: 36218AN: 1461228Hom.: 607 Cov.: 31 AF XY: 0.0252 AC XY: 18305AN XY: 726898
GnomAD4 exome
AF:
AC:
36218
AN:
1461228
Hom.:
Cov.:
31
AF XY:
AC XY:
18305
AN XY:
726898
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0266 AC: 4051AN: 152258Hom.: 73 Cov.: 33 AF XY: 0.0258 AC XY: 1919AN XY: 74456
GnomAD4 genome
AF:
AC:
4051
AN:
152258
Hom.:
Cov.:
33
AF XY:
AC XY:
1919
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
238
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 03, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Congenital contractures of the limbs and face, hypotonia, and developmental delay Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: -10
Find out detailed SpliceAI scores and Pangolin per-transcript scores at